Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Teck Resources
TECK
$31.3B
| $46.3M | 0.04% |
2,667,437
+83,076
| +3% | +$1.36M |
|
552
Radware
RDWR
$1.25B
| $46.3M | 0.04% |
1,794,054
+213,954
| +14% | +$5.07M |
|
553
Tower Semiconductor
TSEM
$28.6B
| $46.3M | 0.04% |
1,922,286
+97,300
| +5% | +$2.19M |
|
554
Ferrari
RACE
$72.5B
| $46.2M | 0.04% |
278,568
-227,475
| -45% | -$36.8M |
|
|
EVRI
555
DELISTED
Everi Holdings
EVRI
| $46.2M | 0.04% |
3,438,000
+324,300
| +10% | +$3.7M |
|
556
Motorola Solutions
MSI
$77B
| $46.2M | 0.04% |
+286,415
| New | +$47.2M |
|
557
Sibanye-Stillwater
SBSW
$7.42B
| $46.1M | 0.04% |
4,641,630
+1,188,700
| +34% | +$9.19M |
|
558
Oracle
ORCL
$450B
| $46M | 0.04% |
+868,732
| New | +$47.8M |
|
559
Constellation Brands
STZ
$23.3B
| $46M | 0.04% |
242,400
-272,700
| -53% | -$51.5M |
|
|
MNR
560
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $45.9M | 0.04% |
3,168,700
+200,434
| +7% | +$2.96M |
|
561
Algonquin Power & Utilities
AQN
$4.48B
| $45.9M | 0.04% |
3,241,686
+936,425
| +41% | +$13M |
|
562
Cal-Maine
CALM
$3.87B
| $45.9M | 0.04% |
1,072,899
-224,809
| -17% | -$9.37M |
|
563
Arrowhead Research
ARWR
$12.1B
| $45.8M | 0.04% |
722,300
+64,700
| +10% | +$3.21M |
|
564
SolarEdge
SEDG
$1.98B
| $45.6M | 0.04% |
479,495
-187,005
| -28% | -$16M |
|
565
Advanced Energy
AEIS
$13.2B
| $45.6M | 0.04% |
639,800
-349,422
| -35% | -$21.7M |
|
566
Nutrien
NTR
$32.2B
| $45.6M | 0.04% |
950,846
+797,936
| +522% | +$38.6M |
|
567
Teladoc Health
TDOC
$1.26B
| $45.4M | 0.03% |
+542,700
| New | +$41.3M |
|
|
SC
568
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $45.4M | 0.03% |
1,941,800
+282,400
| +17% | +$6.86M |
|
|
VAR
569
DELISTED
Varian Medical Systems, Inc.
VAR
| $45.4M | 0.03% |
319,354
+204,554
| +178% | +$26.1M |
|
570
Angi Inc
ANGI
$196M
| $45.3M | 0.03% |
534,614
+158,924
| +42% | +$11.9M |
|
571
Enanta Pharmaceuticals
ENTA
$391M
| $45.2M | 0.03% |
731,600
+68,700
| +10% | +$4.26M |
|
572
Post Holdings
POST
$3.65B
| $45.2M | 0.03% |
632,898
-225,991
| -26% | -$15.5M |
|
|
SIX
573
DELISTED
Six Flags Entertainment Corp.
SIX
| $45.1M | 0.03% |
999,200
+911,100
| +1,034% | +$41.9M |
|
574
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $45.1M | 0.03% |
240,483
+69,602
| +41% | +$11.8M |
|
|
EBSB
575
DELISTED
Meridian Bancorp, Inc.
EBSB
| $44.9M | 0.03% |
2,233,545
+156,501
| +8% | +$3.07M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.